Chemotherapy Side Effects Research-2008 Dec

In 2008, a study with mice was used to determine the effects of a nonpsychoactive cannabinoid cannabidiol, in a mouse model of cisplatin-induced nephropathy. BACKGROUND:: The platinum compound cisplatin is one of the most potent chemotherapy agents available to treat various malignancies. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/

Chemotherapy Side Effects Study-2011 Sep

In 2011, Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients in a randomized, double-blind, placebo-controlled pilot trial BACKGROUND: To determine if delta-9-tetrahydrocannabinol (THC) can improve taste and smell (chemosensory) perception as well as appetite, caloric intake, and quality of life (QOL) for cancer patients with chemosensory alterations. You can read the full article here => https://academic.oup.com/annonc/article/22/9/2086/211788/Delta-9-tetrahydrocannabinol-may-palliate-altered

Chemotherapy Side Effects Study-1994

In 1994, A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. BACKGROUND: Nineteen patients with various malignancies were entered. All had cancer-associated anorexia and a life expectancy greater than four weeks. Patients were started on THC 2.5 mg p.o. t.i.d. one hour after meals for four weeks. Evaluations for side effects, efficacy, acceptability .. Read More